OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Hospital Pharmacy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Medical device resources for hospital pharmacists	77
Advanced therapy medicinal products	54
Medication stability: from pharmacies to patients’ homes—is consistent storage achievable?	19
Broad perspective on the relationship between soticlestat and QT interval in patients with epilepsy	17
Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings	17
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease	14
Natural language processing assisted detection of inappropriate proton pump inhibitor use in adult hospitalised patients	12
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years	11
Reducing the use of sleep-inducing drugs during hospitalisation by a multi-faceted intervention: a pilot study	11
EJHP’s impact factor moves on up	10
Development of a 50% (w/v) aluminium chloride hexahydrate solution as haemostatic agent	10
Empowering European hospital pharmacists in the face of heart failure	10
The threatened medicines information pharmacist!	10
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendations	10
Assessing health outcomes: a systematic review of electronic patient-reported outcomes in oncology	9
Medication safety strategies in European adult, paediatric, and neonatal intensive care units: a cross-sectional survey	9
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze	8
Hypoglycaemic coma induced by a falsified semaglutide product: a case report	8
Development and validation of a feasible questionnaire to assess pharmacists’ attitudes to documenting and classifying pharmaceutical interventions in hospital settings	8
Expanded expiry dates: a regulatory opportunity for Europe	7
Optimisation of the quality of care for patients with severe asthma: ASfarMA project	7
Correspondence on “Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements	6
The end of an era!	6
A retrospective hospital benefit and cost analysis of the management of human tissues for orthopaedic allografts	6
Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis	6

EAHP’s special interest group on hospital pharmacist’s preparedness for in-vivo GTMP publishes report	6
Rare complication of doxorubicin-induced complete heart block in a patient with Hodgkin’s lymphoma: a case report	6
¹⁷⁷Lu-Dotatate administration using an infusion pump or a peristaltic pump: comparison of two methods	6
Hospital pharmacists in cardio-oncology: bridging a critical gap in multidisciplinary cancer care	6
Inhaled aztreonam lysine in the management ofPseudomonas aeruginosain patients with cystic fibrosis: real-life effectiveness	5
Ceftriaxone-induced thrombocytopenia during tuberculosis treatment: a case report	5
A collaborative telepharmacy model for dispensing and informed delivery from hospital to community pharmacies	5
Antifungal prophylaxis against invasive Candida and Aspergillus infection in adult heart transplant recipi	5
Thoughts on the shortage of vinflunine: could we have done more?	5
Beta-lactam allergy in patients: an antibiotic stewardship challenge	5
Risk factors for unintentional medication discrepancies identified through pharmacy staff-led medication reconciliation to prioritise patients in the emergency department: a rapid review	5
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence	5
Response to: Correspondence on ‘Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake	5
EMA guidance for industry to prevent and mitigate medicine shortages	5
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients	5
Challenges and opportunities for hospital pharmacists in the management of gene and cell therapies	5
Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C	5
The importance of authorship integrity in scientific publications within healthcare and hospital pharmacy	5
Pharmaceutical validation of peripherally inserted central catheters: four years of implementation	5
EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations	5
Hydrocortisone-induced blood pressure reduction in a patient with anterior pituitary hypofunction: a case report	5
Drug-induced acute generalised exanthematous pustulosis: insights from FAERS data on a rare but severe cutaneous adverse reaction	4
Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: a retrospective analysis of clinical trial data from 1992 to 2023	4
Women and adverse drug reactions: 56 years of analysis of real-world data collected in the FDA adverse event reporting system (FAERS) database	4
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time	4
Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab	4
Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements	4
Pharmaceutical consultation on patients receiving oral antineoplastic agents: a systematic review	4
Colchicine–enzalutamide interaction: clinical implications and multi-disciplinary management	4
Study of overall survival associated with nintedanib and pirfenidone in patients with idiopathic pulmonary fibrosis: a real-life comparison	3
Automated preparation of cytotoxic drugs: the evidence for an interface between the robot and computerized provider order entry?	3
Capecitabine: guaranteed access in adjuvant treatment of breast cancer	3
In-hospital expenditure for medical devices in relation to funds from diagnosis-related groups and ambulatory activity: temporal trend from 2019 to 2022	3
Update on the hospital pharmacist profile: from clinical practice to management	3
Cannabis hyperemesis syndrome: an emerging clinical and public health challenge	3
Switching of anti-migraine antibodies: effectiveness or regression to the mean?	3
Penicillin allergy that persisted after 66 years: case report	3
Effectiveness and safety of off-label dupilumab use for the treatment of pemphigoid gestationis: a new case report	3
Tocilizumab in COVID-19 management: addressing time of starting treatment	3
Clinical trials	3
Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing	3
Infectious diseases and antimicrobial resistance	3
Medication-related problems in critical care survivors: a systematic review	3
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document	3
Pharmacological resilience in the context of geopolitical tensions: a European perspective	3
A pharmacovigilance study on antiepileptic medications in a paediatric hospital in Italy	3
Implementation of pharmaceutical infusion management to reduce incompatibilities and fluid overload: a retrospective observational study in a paediatric intensive care unit	3
Budd-Chiari syndrome after BNT162b2 mRNA vaccination: two case reports	3
Hypomagnesaemia with niraparib: the need for comprehensive adverse effect reporting in drug labelling	3
Pancytopenia in a patient treated with fusidic acid and niraparib: a case report	3

Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients	3
Organisational impact of in vivo gene therapies at two French injection centres	3
Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags	3
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series	3
How to manage the overwhelming amount of database-detected interactions? A focus group meeting study on the management of database-detected risks of drug interactions	3
The future of pharmacy is already here: can we afford not to invest? Reflections from the seventh EAHP Synergy Certification Course 2025 in Bratislava	3
Role of EMA for crises strengthened	3
Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-19	3
Systematic review of room temperature stability of key beta-lactam antibiotics for extended infusions in inpatient settings	3
Influence of baseline characteristics and stratification level of patients living with HIV on pharmaceutical interventions developed according to the Capacity-Motivation-Opportunity methodology	3
Medication adherence interventions: where are we and where do we go?	3
Digitalisation of the drug prescribing process in Swiss hospitals – results of a survey	3
An antidote network in Spain, a tool to improve antidote availability in hospitals	3
Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration	2
To maximise impact, hospital pharmacists need to increase visibility	2
Comparison of the 22nd World Health Organization Model List of Essential Medicines with the explicit criteria for the treatment of chronicity in elderly patients	2
Clinical and economic benefits of expanded access programs: should we strengthen these pharmacist-led initiatives?	2
Patient safety culture and medication safety in European intensive care units: a focus group study	2
Older people, medication usage and long-term care pharmacists: a retrospective cohort study	2
Digital health	2
Drug intoxication: a silent obstacle to organ donation	2
Assessment of particle contamination in vancomycin syringe pumps following fluid withdrawal using three diverse aseptic reconstitution techniques	2
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients	2
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations	2
Antimicrobial resistance in Nigeria: challenges and charting the way forward	2
Haemodynamic effects of intravenous acetaminophen in critically ill paediatric patients: a retrospective chart review	2
Formulation and stability study of an oral paediatric phenobarbital 1% solution containing hydroxypropyl-β-cyclodextrins	2
Introduction to an online only issue	2
Antimicrobial resistance: a major priority for global focus	2
European health data space proposal launched	2
Factors associated with potential drug–drug interactions in psychiatric inpatients	2
Beyond conventional dosing: tailoring antimicrobial regimens for cachexia	2
Home antibiotic therapy in elastomeric infusion pumps – past, present and future	2
Safeguarding antimicrobial medicines reserved for treating humans	2
Defining a new term: defensive hospital pharmacy practices	2
Complementary and alternative medicine in HIV care: frequency of consumption, risks and interactions with antiretroviral therapy	2
The PEPSIN project: design and validation of a self-administered questionnaire for the assessment of equivalence between pens and prefilled syringes in patients on subcutaneous biological drugs	2
The Granada Statements: an impact boost to clinical and social pharmacy publications, part 1	2
Results of EAHP’s 2023 shortages survey	2
Deep learning classification of drug-related problems from pharmaceutical interventions issued by hospital clinical pharmacists during medication prescription review: a large-scale descriptive retrosp	2
Implementation of pharmacists’ monitoring for intravenous drug compatibility	2
Retrospective study of plasma anti-Xa levels in renally impaired patients receiving reduced or non-reduced therapeutic doses of dalteparin	2
When gravimetry is debated by sponsors of clinical studies	2
Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies	2
Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD	2
Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review	2
Public information on shortages in the EU/EEA: improvements made between 2018 and 2020	2
Comparison of adverse drug reactions of statins in China from 1989 to 2019	2
Integrating automated dispensing cabinets into the medication dispensing process: feedback from the practice in European hospitals	2
Analysing electronic prescribing data to detect potential undocumented adverse reactions to medications	2
Evaluation of resources for effective decision-making about drug manipulation	2
Monitoring of occupational exposure to hazardous medicinal products in robotic compounding	2
Should vericiguat be initiated in geriatric inpatients with heart failure with reduced ejection fraction and a worsening heart failure event prior to discharge?	2
Do junior doctors make more prescribing errors than experienced doctors when prescribing electronically using a computerised physician order entry system combined with a clinical decision support syst	2
Physicochemical stability of a polysorbate-80-containing solvent compounded in the hospital pharmacy and used to reconstitute a biologic for nebulisation	2
Pharmaceutical care in the screening process of phase I oncohaematological clinical trials	2
Looking back and looking forward	2
Primary care electronic medication record discrepancies in patients starting treatment at a hospital-based ambulatory care pharmacy and impact on prevalence of potential drug–drug interactions	2
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment	2
Liquid antimicrobials: a national analysis of critical shortages	2
Study of therapeutic patient education practices in French renal transplantation centres	2
Realising potential and addressing risk: a UK survey of adult hepatology pharmacy services	2
Medication adherence in chronic myeloid leukemia: a hospital pharmacy-level analysis	2
Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients	2